Sino Biopharmaceutical Limited

1177.HK·HKSE·Healthcare
Compare
5.625+0.475 (+9.22%)today
At close: Nov 5, 4:08 PM HKT · May be delayed up to 15 min · HKD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close5.150
Open5.375
Day range5.2605.640
52-week range4.1907.480
Off day high−0.27%
Off 52-week high−24.80%
Volume212.95M
Avg. volume (3M)76.99M
Market cap100.09B
EPS (TTM)0.1500
Forward P/E17.66
P/E ratio (TTM)37.50
Dividend yield2.72% (0.1400)
Beta (5Y)0.65
Shares outstanding17.79B
Short interest—
Earnings dateAug 19, 2026
Analyst target8.466
Profit margin7.09%

Against its peers

Compare in full ›
1177.HK 2696.HK 1530.HK 6IB.F 688266.SS 6990.HK
Market cap 100.09B 27.67B 37.99B 17.27B 24.15B 110.38B
P/E (TTM) 37.5 28.8 4.1 123.8 42.6 641.4
Forward P/E 17.7 28.2 11.2 — 73.0 141.1
Price/book 2.6 5.2 1.2 6.2 14.1 17.2
Dividend yield 2.72% — 1.69% — — —
1-year change −26.32% −19.71% −51.32% −1.76% −10.38% +1.89%
Today +9.22% +1.78% +4.00% +3.42% +0.12% +4.39%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All 1177.HK news ›
SRN News··2 outletsPositive

Sino Biopharmaceutical, Boehringer ink cancer drug deal worth $7 billion in milestones

• The Chinese drugmaker will receive $358 million in upfront and near-term payments under the deal, it said • The deal covers six preclinical cancer programs spanning antibody-drug conjugates, which use antibodies to deliver toxic drugs…

More from 1 other outlet

From the 4Search news index, newest first.

In the news

5mentions in 30 days
5with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 5 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance